Sumitomo Chemical Advanced Medical

Tokyo, JP
Hybrid — also manufactures internal programs
Oligonucleotide Cell Therapy
Program data pending ClinicalTrials.gov matching · Last scored 2026-04-02
63.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Sumitomo Chemical Advanced Medical

Signal Score
63.0/100 (as of 2026-04-02)
Quality Compliance
Assessment pending
Headquarters
Tokyo, JP
Modalities
Oligonucleotide, Cell Therapy
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesOligonucleotide, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: Sumitomo Chemical
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Sumitomo Chemical
Financial assessment: 68.0/100
Capacity 58.0
1 manufacturing site: Tokyo, JP
Modalities: Oligonucleotide, Cell Therapy
Capacity assessment: 58.0/100
Sites: Tokyo, JP
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Tokyo, JP
Modalities: Oligonucleotide, Cell Therapy
Capacity assessment: 58.0/100
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Oligonucleotide CDMOs → Cell Therapy CDMOs →

Similar CDMOs

Minaris Advanced Therapies
Philadelphia, PA · Allendale, NJ · Munich, DE · Yokohama, JP
Signal Score: 83.5
CAR-T, Cell Therapy
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 80.2
CAR-T, Cell Therapy, AAV, Lentiviral
Hitachi Global Life Solutions (CGT)
Yokohama, JP
Signal Score: 63.0
Cell Therapy, CAR-T
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral